Stay updated on Inetetamab Plus Rapamycin for HER2+ Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Inetetamab Plus Rapamycin for HER2+ Breast Cancer Clinical Trial page.

Latest updates to the Inetetamab Plus Rapamycin for HER2+ Breast Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedThe new screenshot shows an updated submission date in the Study Record Versions section for NCT04736589, while the rest of the page content remains the same. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check40 days agoChange DetectedAdded a government operating-status notice and updated version to v3.2.0; removed the previous v3.1.0 tag.SummaryDifference13%

- Check48 days agoChange DetectedVersion tag updated from v3.0.2 to v3.1.0, indicating an updated release.SummaryDifference0.3%

- Check62 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; no other content changes detected.SummaryDifference0.3%

- Check69 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.3%

- Check76 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, while several location-related terms and details have been removed.SummaryDifference4%

Stay in the know with updates to Inetetamab Plus Rapamycin for HER2+ Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inetetamab Plus Rapamycin for HER2+ Breast Cancer Clinical Trial page.